Routine Spironolactone in Acute Myocardial Infarction
New England Journal of Medicine, Ahead of Print.
massmed: New England Journal of Medicine: Table of Contents
Colchicine in Acute Myocardial Infarction
In a randomized trial involving patients with acute myocardial infarction, colchicine did not decrease the risk of major adverse cardiovascular events over a median...
NEJM at AHA — Routine Spironolactone in Acute Myocardial Infarction
In this audio interview, Editor-in-Chief Eric Rubin and Deputy Editor Jane Leopold discuss research being presented at the 2024 American Heart Association Scientific Sessions....
Routine Spironolactone in Acute Myocardial Infarction
In a large trial involving patients with acute myocardial infarction, 95% of whom had ST-segment elevation myocardial infarction, spironolactone did not reduce the risk...
NEJM at AHA — CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy
New England Journal of Medicine, Ahead of Print.
massmed: New England Journal of Medicine: Table of Contents
